Pittsburgh Compound B: Clinical Trials

6 trials of Pittsburgh Compound B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated. 3 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Early Phase 11Completed 1

Follow Pittsburgh Compound B: new trials by email Literature Review of Pittsburgh Compound B trials Research Report on Pittsburgh Compound B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
University of Pittsburgh Brain Health Initiative
Cognitive/Neuropsychological Testing, Vestibular/Ocular-Motor Testing, Sleep Evaluation - Traumatic Brain Injury
RecruitingDavid Okonkwo, MD, PhD3002019-11-182026-06-22
[C-11]PiB PET Imaging in Alcohol Use Disorders
[C-11], Pittsburgh Compound B - Alcohol Use Disorder
Early Phase 1CompletedUniversity of Pittsburgh392018-12-012024-12-13
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
11C-PiB - Alzheimer Disease, Healthy Aging
TerminatedUniversity of Colorado, Denver252016-11-222023-04-07
Florbetapir Calibration to the Centiloid Scale
Florbetapir (18F), 11C-PiB - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals352014-04-012017-03-09
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
C-11 PiB - Atypical Alzheimers Disease, Logopenic Variant of Primary Progressive Aphasia (LPA)
Phase 1CompletedMayo Clinic272012-11-012015-12-21
PiB PET Scanning in Speech and Language Based Dementias
C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia
Phase 1CompletedMayo Clinic1682010-03-012015-12-22

Conditions studied

Alzheimer Disease (2)  ·  Aphasia (2)  ·  Alcoholism (1)  ·  Aphasia, Broca (1)  ·  Aphasia, Primary Progressive (1)  ·  Apraxias (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Frontotemporal Dementia (1)  ·  Language (1)  ·  Primary Progressive Nonfluent Aphasia (1)

Sponsors

Mayo Clinic (2)  ·  Avid Radiopharmaceuticals (1)  ·  David Okonkwo, MD, PhD (1)  ·  University of Colorado, Denver (1)  ·  University of Pittsburgh (1)

Countries

United States (6)  ·  Australia (1)

Top investigators

Brianne M Bettcher, Ph.D. (1)  ·  David O Okonkwo, MD, PhD (1)  ·  Jennifer Whitwell, PhD (1)  ·  Keith A Josephs, M.D. MST, MSc (1)

Results publications

PMID 33934110

NIH funding

R01AA025247 (1)